Medroxyprogesterone Acetate antibody
EIA
Host: Sheep
Polyclonal
unconjugated
-
- Target See all Medroxyprogesterone Acetate products
- Medroxyprogesterone Acetate
- Reactivity
- Please inquire
-
Host
-
Sheep
-
Clonality
- Polyclonal
-
Conjugate
- This Medroxyprogesterone Acetate antibody is un-conjugated
-
Application
- Enzyme Immunoassay (EIA)
- Purification
- Ig Fraction
- Immunogen
- Medroxyprogesterone acetate (3)-BTG
- Isotype
- IgG
-
-
- Application Notes
-
ELISA: 0.1 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 9.70mg/mL (U.V. abs at 280nm)
- Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Avoid repeated freezing and thawing.
- Storage
- -20 °C
-
- Target
- Medroxyprogesterone Acetate
- Abstract
- Medroxyprogesterone Acetate Products
- Target Type
- Chemical
- Background
- MPA (also known as depo provera) is a highly potent progestational steroid that has been used worldwide as a contraceptive. There has been a concern about the possibility of an increased risk of breast cancer associated with its use. On the other hand, MPA when employed at high doses (>0.5 - 1.0g / day i.m.) can produce objective remission with improved survival in about 30?% of postmenopausal women with advanced breast cancer resistant to cytotoxic drugs and endocrine therapies. Early results suggest that the response rate can be increased in patients with estrogen and / or progesterone positive receptors.Synonyms: MPA, Medroxy Progesterone Acetate, depo provera
-
You are here:
